Utrecht (The Nether\u00adlands) \u2014 Gilde Health\u00adcare announ\u00adces the final closing of the new Venture&Growth Fund VI with a volume of EUR 740 million. Fund VI thus closes at the upper end of the target volume after announ\u00adcing an initial closing of EUR 600 million in April of this year. The new fund focu\u00adses on fast-growing compa\u00adnies that deve\u00adlop solu\u00adti\u00adons for impro\u00adved health\u00adcare at lower costs.<\/p>\n
Gilde Health\u00adcare invests in compa\u00adnies in Europe and North America that are active in areas such as digi\u00adtal health, medi\u00adcal tech\u00adno\u00adlogy and thera\u00adpeu\u00adtics. Gilde Health\u00adcare Venture&Growth VI is an Article 9 fund in the context of the Sustainable Finance Disclo\u00adsure Regu\u00adla\u00adtion (SFDR).<\/p>\n
Inves\u00adtors include compa\u00adnies from the health\u00adcare sector, pension funds, banks, insu\u00adrance compa\u00adnies, funds of funds and sove\u00adreign wealth funds, foun\u00adda\u00adti\u00adons, family offices, entre\u00adpre\u00adneurs and the Gilde team.<\/p>\n
Pieter van der Meer, Mana\u00adging Part\u00adner at Gilde Health\u00adcare<\/strong>: \u201cThe strong inte\u00adrest from insti\u00adtu\u00adtio\u00adnal inves\u00adtors who want to make a sustainable impact with their invest\u00adments is a clear confir\u00adma\u00adtion of our mission: inves\u00adt\u00ading in solu\u00adti\u00adons that improve the quality of pati\u00adent care and are cost-effec\u00adtive at the same time. Our holi\u00adstic and broad-based stra\u00adtegy, which includes invest\u00adments in digi\u00adtal health, medi\u00adcal tech\u00adno\u00adlogy and thera\u00adpeu\u00adtics in parti\u00adcu\u00adlar, enables us to find the best and most cost-effec\u00adtive solu\u00adtion for each indi\u00advi\u00addual pati\u00adent. With our team of expe\u00adri\u00aden\u00adced indus\u00adtry experts, we help compa\u00adnies to scale medi\u00adcal inno\u00adva\u00adtions and make them acces\u00adsi\u00adble worldwide.\u201d<\/p>\n Spen\u00adding on health\u00adcare in the western world is rising steadily and alre\u00adady exceeds 20% of GDP in the United States. Society as a whole needs cost-effec\u00adtive solu\u00adti\u00adons to coun\u00adter this growth in expen\u00addit\u00adure. Gilde Health\u00adca\u00adre\u2019s mission to invest in impro\u00adved health\u00adcare at lower cost is supported by the newly formed Impact Coun\u00adcil, chai\u00adred by the former Execu\u00adtive Direc\u00adtor of the Euro\u00adpean Medi\u00adci\u00adnes Agency (EMA).<\/p>\n The new fund will invest 10\u201370 million euros per port\u00adfo\u00adlio company. Toge\u00adther with the last Venture&Growth Fund V (2020) and Gilde Health\u00adcare Private Equity IV (2022), Gilde Health\u00adcare has raised EUR 1.7 billion in capi\u00adtal in the last three years.<\/p>\n About Gilde Healthcare Utrecht (The Nether\u00adlands) \u2014 Gilde Health\u00adcare announ\u00adces the final closing of the new Venture&Growth Fund VI with a volume of EUR 740 million. Fund VI thus closes at the upper end of the target volume after announ\u00adcing an initial closing of EUR 600 million in April of this year. The new fund focu\u00adses on fast-growing [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":49949,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1368,1369],"tags":[],"class_list":["post-49951","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-lawyers-tax-consultants-auditors","category-investors"],"yoast_head":"\n
\n<\/strong>
\nGilde Health\u00adcare is an inves\u00adtor specia\u00adli\u00adzing in the health\u00adcare sector that mana\u00adges over 2.6 billion euros with two fund stra\u00adte\u00adgies: Venture&Growth and Private Equity. Gilde Health\u00adca\u00adre\u2019s Venture&Growth fund invests in fast-growing compa\u00adnies in the fields of digi\u00adtal health, medi\u00adcal tech\u00adno\u00adlogy and thera\u00adpeu\u00adtics based in Europe and North America. Gilde Health\u00adca\u00adre\u2019s private equity fund invests in profi\u00adta\u00adble, medium-sized health\u00adcare compa\u00adnies based in north-western Europe. Further infor\u00adma\u00adtion can be found at: www.gildehealthcare.com<\/p>\n","protected":false},"excerpt":{"rendered":"